Cargando…

Derivation and Validation of a Phenoconversion‐Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder

BACKGROUND: Idiopathic rapid eye movement sleep behavior disorder (iRBD) represents the prodromal stage of α‐synucleinopathies. Reliable biomarkers are needed to predict phenoconversion. OBJECTIVE: The aim was to derive and validate a brain glucose metabolism pattern related to phenoconversion in iR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mattioli, Pietro, Orso, Beatrice, Liguori, Claudio, Famà, Francesco, Giorgetti, Laura, Donniaquio, Andrea, Massa, Federico, Giberti, Andrea, Vállez García, David, Meles, Sanne K., Leenders, Klaus L., Placidi, Fabio, Spanetta, Matteo, Chiaravalloti, Agostino, Camedda, Riccardo, Schillaci, Orazio, Izzi, Francesca, Mercuri, Nicola B., Pardini, Matteo, Bauckneht, Matteo, Morbelli, Silvia, Nobili, Flavio, Arnaldi, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092506/ https://www.ncbi.nlm.nih.gov/pubmed/36190111 http://dx.doi.org/10.1002/mds.29236

Ejemplares similares

Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort
por: Orso, Beatrice, et al.
Publicado: (2023)

Stratification Tools for Disease‐Modifying Trials in Prodromal Synucleinopathy
por: Arnaldi, Dario, et al.
Publicado: (2021)

Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease
por: Orso, Beatrice, et al.
Publicado: (2021)

Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center
por: Vacca, Mariacarolina, et al.
Publicado: (2021)

Sleep Dysregulation Is Associated with (18)F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
por: Fernandes, Mariana, et al.
Publicado: (2023)

The Sleepiness–Depression Link in Obstructive Sleep Apnea: Preliminary Results on the Mediation of Impulsivity
por: Vacca, Mariacarolina, et al.
Publicado: (2023)

Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD)
por: Brugnolo, Andrea, et al.
Publicado: (2021)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
por: Bauckneht, Matteo, et al.
Publicado: (2018)

The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia
por: Orso, Beatrice, et al.
Publicado: (2022)

(18)F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment
por: Fernandes, Mariana, et al.
Publicado: (2022)

Metabolic signature of hyposmia after mild COVID-19: An [18]F-FDG-pet study
por: Pardini, Matteo, et al.
Publicado: (2021)

Phase and amplitude electroencephalography correlations change with disease progression in people with idiopathic rapid eye-movement sleep behavior disorder
por: Roascio, Monica, et al.
Publicado: (2021)

Brain Metabolic Correlates of Persistent Olfactory Dysfunction after SARS-Cov2 Infection
por: Donegani, Maria Isabella, et al.
Publicado: (2021)

(123)I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies
por: Pardini, Matteo, et al.
Publicado: (2020)

Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers
por: Bauckneht, Matteo, et al.
Publicado: (2019)

Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap
por: Morbelli, Silvia, et al.
Publicado: (2022)

Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective
por: Ricci, Maria, et al.
Publicado: (2021)

Commentary: Sleep Changes without Medial Temporal Lobe or Brain Cortical Changes in Community-Dwelling Individuals with Subjective Cognitive Decline
por: Liguori, Claudio, et al.
Publicado: (2017)

The Alzheimer’s disease metabolic brain pattern in mild cognitive impairment
por: Meles, Sanne K, et al.
Publicado: (2017)

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine
por: Liguori, Claudio, et al.
Publicado: (2018)

Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?
por: Bauckneht, Matteo, et al.
Publicado: (2017)

Functional Correlates of Microglial and Astrocytic Activity in Symptomatic Sporadic Alzheimer’s Disease: A CSF/(18)F-FDG-PET Study
por: Bonomi, Chiara Giuseppina, et al.
Publicado: (2023)

Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
por: De Masi, Claudia, et al.
Publicado: (2022)

Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake
por: Bauckneht, Matteo, et al.
Publicado: (2021)

Restless Legs Syndrome and Poliomyelitis: New Evidences of an Old Observation?
por: Romigi, Andrea, et al.
Publicado: (2015)

Dasatinib-induced nephrotic syndrome: a case of phenoconversion?
por: Mandac Rogulj, Inga, et al.
Publicado: (2019)

Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion
por: Gharaee-Kermani, Mehrnaz, et al.
Publicado: (2016)

Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
por: Meles, Sanne K., et al.
Publicado: (2019)

Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study “FARPRESTO”
por: Puligheddu, Monica, et al.
Publicado: (2022)

CXC-Type Chemokines Promote Myofibroblast Phenoconversion and Prostatic Fibrosis
por: Gharaee-Kermani, Mehrnaz, et al.
Publicado: (2012)

The role of club cell phenoconversion and migration in idiopathic pulmonary fibrosis
por: Fukumoto, Jutaro, et al.
Publicado: (2016)

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review
por: Klomp, Sylvia D., et al.
Publicado: (2020)

Cardiosomal microRNAs Are Essential in Post-Infarction Myofibroblast Phenoconversion
por: Morelli, Marco B., et al.
Publicado: (2019)

Sleep Disturbances and Phenoconversion in Patients with REM Sleep Behavior Disorder
por: Jo, Hyunjin, et al.
Publicado: (2021)

Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients
por: den Uil, Manon G., et al.
Publicado: (2023)

Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid
por: Liguori, Claudio, et al.
Publicado: (2019)

Correction to: Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study “FARPRESTO”
por: Puligheddu, Monica, et al.
Publicado: (2022)

Sleep architecture in drug‐naïve adult patients with epilepsy: Comparison between focal and generalized epilepsy
por: Calvello, Carmen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4q0v86r3p60iop2te4rpuoralk